State-of-the-art acute and chronic GVHD treatment

Post-Transplant High-Dose Cyclophosphamide for the Prevention of Graft-versus-Host Disease

(2015) Ahmad Samer Al-Homsi et al.   BIOLOGY OF BLOOD AND MARROW TRANSPLANTATION

National Institutes of Health Consensus Development Project on Criteria for Clinical Trials in Chronic Graft-versus-Host Disease: I. The 2014 Diagnosis and Staging Working Group Report

(2015) Madan H. Jagasia et al.   BIOLOGY OF BLOOD AND MARROW TRANSPLANTATION

A Phase II Study of Bortezomib Plus Prednisone for Initial Therapy of Chronic Graft-versus-Host Disease

(2014) Alex F. Herrera et al.   BIOLOGY OF BLOOD AND MARROW TRANSPLANTATION

Tacrolimus/sirolimus vs tacrolimus/methotrexate as GVHD prophylaxis after matched, related donor allogeneic HCT

(2014) C. Cutler et al.   BLOOD

Long-term outcome after haploidentical stem cell transplant and infusion of T cells expressing the inducible caspase 9 safety transgene

(2014) X. Zhou et al.   BLOOD

 -1-Antitrypsin (AAT)-modified donor cells suppress GVHD but enhance the GVL effect: a role for mitochondrial bioenergetics

(2014) A. M. Marcondes et al.   BLOOD

Hematopoietic stem cell transplantation donor sources in the 21st century: choosing the ideal donor when a perfect match does not exist

(2014) N. Kekre et al.   BLOOD

Phase 3 clinical trial of steroids/mycophenolate mofetil vs steroids/placebo as therapy for acute GVHD: BMT CTN 0802

(2014) J. Bolanos-Meade et al.   BLOOD

Ibrutinib treatment ameliorates murine chronic graft-versus-host disease

(2014) Jason A. Dubovsky et al.   JOURNAL OF CLINICAL INVESTIGATION

A comparative assessment of the curative potential of reduced intensity allografts in acute myeloid leukaemia

(2014) N H Russell et al.   LEUKEMIA

Haploidenticalvscord blood transplantation for adults with acute myelogenous leukemia

(2014) Melhem Solh   World Journal of Stem Cells

Prophylactic rituximab after allogeneic transplantation decreases B-cell alloimmunity with low chronic GVHD incidence

(2012) S. Arai et al.   BLOOD

Diagnosis and management of chronic graft-versus-host disease

(2012) Fiona L. Dignan et al.   BRITISH JOURNAL OF HAEMATOLOGY

Mesenchymal stromal cells: a key player in ‘innate tolerance’?

(2012) Francesco Dazzi et al.   IMMUNOLOGY

Bortezomib-Based Graft-Versus-Host Disease Prophylaxis in HLA-Mismatched Unrelated Donor Transplantation

(2012) John Koreth et al.   JOURNAL OF CLINICAL ONCOLOGY

Blockade of Lymphocyte Chemotaxis in Visceral Graft-versus-Host Disease

(2012) Ran Reshef et al.   NEW ENGLAND JOURNAL OF MEDICINE

Tocilizumab for the Treatment of Steroid Refractory Graft-versus-Host Disease

(2011) William R. Drobyski et al.   BIOLOGY OF BLOOD AND MARROW TRANSPLANTATION

Dasatinib as Salvage Therapy for Steroid Refractory and Imatinib Resistant or Intolerant Sclerotic Chronic Graft-versus-Host Disease

(2011) Isabel Sánchez-Ortega et al.   BIOLOGY OF BLOOD AND MARROW TRANSPLANTATION

Comparative analysis of risk factors for acute graft-versus-host disease and for chronic graft-versus-host disease according to National Institutes of Health consensus criteria

(2011) M. E. D. Flowers et al.   BLOOD

Novel treatment concepts for graft-versus-host disease

(2011) D. Wolf et al.   BLOOD

Circulating B-cell activating factor level predicts clinical response of chronic graft-versus-host disease to extracorporeal photopheresis

(2011) R. Whittle et al.   BLOOD

Tregs prevent GVHD and promote immune reconstitution in HLA-haploidentical transplantation

(2011) M. Di Ianni et al.   BLOOD

Prognostic value of response after upfront therapy for acute GVHD

(2011) R M Saliba et al.   BONE MARROW TRANSPLANTATION

Efficacy of bimonthly extracorporeal photopheresis in refractory chronic mucocutaneous GVHD

(2011) F L Dignan et al.   BONE MARROW TRANSPLANTATION

Effectiveness of subcutaneous low-dose alemtuzumab and rituximab combination therapy for steroid-resistant chronic graft-versus-host disease

(2011) C. H. Gutierrez-Aguirre et al.   HAEMATOLOGICA

Depletion of alloreactive T-cells in vitro using the proteasome inhibitor bortezomib preserves the immune response against pathogens

(2011) Belén Blanco et al.   LEUKEMIA RESEARCH

Interleukin-2 and Regulatory T Cells in Graft-versus-Host Disease

(2011) John Koreth et al.   NEW ENGLAND JOURNAL OF MEDICINE

Consensus Conference on Clinical Practice in Chronic Graft-versus-Host Disease (GVHD): First-Line and Topical Treatment of Chronic GVHD

(2010) Daniel Wolff et al.   BIOLOGY OF BLOOD AND MARROW TRANSPLANTATION

Therapy of Sclerodermatous Chronic Graft-Versus-Host Disease with Mammalian Target of Rapamycin Inhibitors

(2010) Zuzana Jedlickova et al.   BIOLOGY OF BLOOD AND MARROW TRANSPLANTATION

Interleukin-6 Modulates Graft-versus-Host Responses after Experimental Allogeneic Bone Marrow Transplantation

(2010) I. Tawara et al.   CLINICAL CANCER RESEARCH

First-Line Therapy for Chronic Graft-versus-Host Disease that Includes Low-Dose Methotrexate Is Associated with a High Response Rate

(2009) Yu Wang et al.   BIOLOGY OF BLOOD AND MARROW TRANSPLANTATION

Alemtuzumab as Treatment of Steroid-Refractory Acute Graft-versus-Host Disease: Results of a Phase II Study

(2009) Carmen Martínez et al.   BIOLOGY OF BLOOD AND MARROW TRANSPLANTATION

Rituximab Treatment before Reduced-Intensity Conditioning Transplantation Associates with a Decreased Incidence of Extensive Chronic GVHD

(2009) Suzanne van Dorp et al.   BIOLOGY OF BLOOD AND MARROW TRANSPLANTATION

A Phase III Study of Infliximab and Corticosteroids for the Initial Treatment of Acute Graft-versus-Host Disease

(2009) Daniel R. Couriel et al.   BIOLOGY OF BLOOD AND MARROW TRANSPLANTATION

Efficacy of Rituximab in the Setting of Steroid-Refractory Chronic Graft-versus-Host Disease: A Systematic Review and Meta-Analysis

(2009) Mohamed A. Kharfan-Dabaja et al.   BIOLOGY OF BLOOD AND MARROW TRANSPLANTATION

Imatinib mesylate as salvage therapy for refractory sclerotic chronic graft-versus-host disease

(2009) L. Magro et al.   BLOOD

Imatinib for refractory chronic graft-versus-host disease with fibrotic features

(2009) A. Olivieri et al.   BLOOD

Etanercept, mycophenolate, denileukin, or pentostatin plus corticosteroids for acute graft-versus-host disease: a randomized phase 2 trial from the Blood and Marrow Transplant Clinical Trials Network

(2009) A. M. Alousi et al.   BLOOD

The role of B cells in the pathogenesis of graft-versus-host disease

(2009) A. Shimabukuro-Vornhagen et al.   BLOOD

Acute graft-versus-host disease: from the bench to the bedside

(2009) G. Socie et al.   BLOOD

Proportions of immature CD19+CD21- B lymphocytes predict the response to extracorporeal photopheresis in patients with chronic graft-versus-host disease

(2009) Z. Kuzmina et al.   BLOOD

Blockade of interleukin-6 signaling augments regulatory T-cell reconstitution and attenuates the severity of graft-versus-host disease

(2009) X. Chen et al.   BLOOD

Sirolimus for treatment of steroid-refractory acute graft-versus-host disease

(2009) D Hoda et al.   BONE MARROW TRANSPLANTATION

Therapy with mycophenolate mofetil for refractory acute and chronic GVHD

(2009) T Furlong et al.   BONE MARROW TRANSPLANTATION

Mycophenolate mofetil for the management of steroid-refractory acute graft vs host disease

(2009) J Pidala et al.   BONE MARROW TRANSPLANTATION

Improved Survival and Preserved Antiviral Responses After Combination Therapy With Daclizumab and Infliximab in Steroid-refractory Graft-Versus-Host Disease

(2009) Kanchan Rao et al.   JOURNAL OF PEDIATRIC HEMATOLOGY ONCOLOGY

Chronic phototoxicity and aggressive squamous cell carcinoma of the skin in children and adults during treatment with voriconazole

(2009) Edward W. Cowen et al.   JOURNAL OF THE AMERICAN ACADEMY OF DERMATOLOGY

The thymus in GVHD pathophysiology

(2008) Werner Krenger et al.   BEST PRACTICE & RESEARCH CLINICAL HAEMATOLOGY

Chronic Graft-versus-Host Disease—Implementation of the National Institutes of Health Consensus Criteria for Clinical Trials

(2008) Linda M. Griffith et al.   BIOLOGY OF BLOOD AND MARROW TRANSPLANTATION

Initial therapy of acute graft-versus-host disease with low-dose prednisone does not compromise patient outcomes

(2008) M. Mielcarek et al.   BLOOD

Change in plasma tumor necrosis factor receptor 1 levels in the first week after myeloablative allogeneic transplantation correlates with severity and incidence of GVHD and survival

(2008) S. W. Choi et al.   BLOOD

A multicenter prospective phase 2 randomized study of extracorporeal photopheresis for treatment of chronic graft-versus-host disease

(2008) M. E. D. Flowers et al.   BLOOD

Extracorporeal photopheresis for the treatment of steroid refractory acute GVHD

(2008) P Perfetti et al.   BONE MARROW TRANSPLANTATION

U.K. consensus statement on the use of extracorporeal photopheresis for treatment of cutaneous T-cell lymphoma and chronic graft-versus-host disease

(2008) J.J. Scarisbrick et al.   BRITISH JOURNAL OF DERMATOLOGY

High response rate and improved graft-versus-host disease following bortezomib as salvage therapy after reduced intensity conditioning allogeneic stem cell transplantation for multiple myeloma

(2008) J. El-Cheikh et al.   HAEMATOLOGICA

B-cell involvement in chronic graft-versus-host disease

(2008) R. Kapur et al.   HAEMATOLOGICA

Mesenchymal stem cells for treatment of steroid-resistant, severe, acute graft-versus-host disease: a phase II study

(2008) Katarina Le Blanc et al.   LANCET

Current and future approaches for control of graft-versus-host disease

(2008) John Koreth et al.   Expert Review of Hematology

Alemtuzumab for the Treatment of Steroid-Refractory Acute Graft-Versus-Host Disease

(2007) David Gómez-Almaguer et al.   BIOLOGY OF BLOOD AND MARROW TRANSPLANTATION